2018美国佛罗里达大学放射肿瘤科指南：分化型甲状腺癌的I-131治疗或外放射治疗.pdfVIP

REVIEW ARTICLE The University of Florida Department of Radiation Oncology Guidelines for Treatment of Differentiated Thyroid Cancer With I-131 or External-beam Radiotherapy Robert J. Amdur, MD* and Roi Dagan, MD † scan, and post treatment whole-body scan. Table 3 summarizes Abstract: The purpose of this paper is to summarize the University of each of these tests. Florida Department of Radiation Oncology guidelines for treatment of dif- ferentiated thyroid cancer with I-131 or external-beam radiotherapy. This article is not meant to compete with the many excellent book chapters and I-131 HALF-LIFE VALUES consensus guidelines that present comprehensive discussions of treatment It is sometimes useful to know the typical half-life values options. This is a streamlined, “How we do it?” reference without substantial discussion of background or supporting data. To serve as a treatment refer- for I-131 in the typical human patient under conditions of ence, the great majority of the information is presented in topic-specific tables. treatment with I-131 for thyroid cancer. In normal thyroid tis- sue, and most DTC, the approximate half-life values are: Key Words: differentiated thyroid cancer, radiotherapy, I-131, external beam physical, 8 days; niologic, 80 days; and effective, 7.3 days. In (Am J Clin Oncol 2018;00:000–000) non–thyroid-related body tissues, the v